Category: Regulatory/FDA

AAMC Sees No Need to Cut Off Contacts With Industry

The Cost of Purity for ACCME

AMA Rejects CEJA Industry Collaboration Report for 4th Time

FDA Launches Bad Ad Program

Roundup of Education and Marketing Issues in Light of Health Reform Passage

Study: The Prohibition of Commercial Support Is Not Needed

FDA Watch: There's More to the New DDMAC Than Just a New Name

Coalition and Med Ad News Present Healthcare Podcasts

Study Finds CME Funding Doesn't Create Bias